Largest Clinical Trials companies in Switzerland by Market Capitalization
Switzerland
# |
Name |
Market Capitalization |
Reported Date | Stock Price |
Change |
Price (30 days) | Country |
|---|---|---|---|---|---|---|---|
| 1 |
USD 2.93 B |
Jan. 14, 2025 | USD 46.50 | 2.74% |
|
Switzerland |
|
| 2 |
USD 201.90 M |
Jan. 14, 2025 | USD 5.48 | 3.60% |
|
Switzerland |
|
| 3 |
USD 165.34 M |
Jan. 14, 2025 | USD 1.71 | -0.58% |
|
Switzerland |
|
| 4 |
USD 5.60 M |
Jan. 14, 2025 | USD 2.03 | -1.93% |
|
Switzerland |
Frequently Asked Questions
-
Which Clinical Trials company in Switzerland has the highest Market Capitalization ?
The Clinical Trials company in Switzerland with the highest Market Capitalization is MoonLake Immunotherapeutics (NasdaqCM: MLTX) at USD 2.93 B.
-
Which Clinical Trials company in Switzerland has the lowest Market Capitalization ?
The Clinical Trials company in Switzerland with the lowest Market Capitalization is NLS Pharmaceutics AG (NasdaqCM: NLSP) at USD 5.60 M.
-
What are the top 10 Clinical Trials companies in Switzerland by Market Capitalization ?
The top 10 Clinical Trials companies in Switzerland by Market Capitalization are MoonLake Immunotherapeutics, Molecular Partners AG, ADC Therapeutics SA and NLS Pharmaceutics AG.
-
What are the bottom 10 Clinical Trials companies in Switzerland by Market Capitalization ?
The bottom 10 Clinical Trials companies in Switzerland by Market Capitalization are NLS Pharmaceutics AG, ADC Therapeutics SA, Molecular Partners AG and MoonLake Immunotherapeutics.